Reordering the pecking order: management describes the company winning on a stage where it used to be too small to play
The model's full reasoning — Q3 2018 call → NOWe need to determine if management conveys that the company has moved up a tier in its market, and that this is already producing real results in the current period. The transcript mentions several developments: Perkin Elmer partnership, HemeScreen, IV-Cell, pathology services growth. But the key is whether management explicitly describes a change in tier—competing against larger players, being considered for business previously out of reach, etc. Looking at the transcript: Ilan discusses the Perkin Elmer agreement. He says: "Perkin Elmer is a multi-billion dollar market leader in our space... they make for a terrific partner to grow our ICP business." He emphasizes that Perkin Elmer selected ICP as a DNA enrichment technology. This suggests that a major industry player has chosen their technology, which could indicate a change in standing. However, does management explicitly say that this is a new level of competition? He says: "This is not the first indicator that we have a strong competitive and valuable technology... but is definitely a strong indicator of the revenue potential." He doesn't explicitly contrast with previous inability to compete at that level. He also mentions "The co-marketing agreement recently announced is the first step in building a strong ongoing relationship." That suggests it's early. But the question asks: does management convey that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? That is, a change in tier. The Perkin Elmer partnership is a major deal, but is it described as a change in tier? Management doesn't say "previously we couldn't get such partnerships" or "we are now being considered for deals we weren't before." They just present it as a positive development. Also, they mention "several potential collaborations with other companies" but that's future. The pathology services growth: they say revenues grew 50% from previous quarter, and they expect to exceed $1 million per quarter by mid-2019. That's growth but not necessarily a tier change. HemeScreen: they launched it and have orders, but again, it's a new product, not necessarily a tier change. The question specifically asks for a coherent development where the company's standing has moved up a tier, and that promotion is already showing up in business actually won.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| PFIE | Profire Energy, Inc. | Q1 2023 | 2023-05-13 | B |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
PRIM · Q2 2018 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing exactly this tier shift in the T&D segment: after the Willbros acquisition, the group “has been able to sign new awards with customers that have been hesitant because of previous concerns about their financial viability” and has received work from “some of the largest electrical utilities in the country.” David King notes that the work “outpaces anything he has seen in his 40-plus years,” and Pete Moerbeek adds that the one-year MSA revenue alone is now $1.1 million. Management presents these wins as a direct result of Primoris’s financial strength and parent-company backing, which previously excluded the T&D business from the largest accounts. The commentary frames the development as newly enabled and still early (only one month of T&D performance), satisfying all three required elements: a clear change in competitive tier, real business already won, and contribution still incremental relative to the company’s prior scale.
SANG · Q2 2024 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management describing a shift to competing at a higher tier with sophisticated mid-market clients through bundled offerings, illustrated by a recent win with a statewide park department that larger vendors couldn't serve affordably. They explicitly note this represents a change in tier ("the type of client the bundled capabilities of Sangoma can reach ... Sangoma is well positioned to play in both the small market and more sophisticated mid-market") and that it has already produced real results ("this recent win"), while conveying it is early ("there'll be a lag before it delivers material results.
WD · Q2 2022 → YESThe question is: Does management describe that the company is NOW COMPETING AND WINNING AT A LEVEL OF THE MARKET THAT USED TO BE ABOVE IT? YES The transcript shows management explicitly describing a tier shift: from competing "predominantly with the likes of JPMorgan and Wells Fargo" to "going head-to-head with CBRE and JLL," enabled by technology investments that now allow them to "successfully compete against these much larger firms.